News about "Songdo Plant 1 in South Korea"

LOTTE Biologics Secures Commercial Manufacturing Agreement for Songdo Plant 1

LOTTE Biologics Secures Commercial Manufacturing Agreement for Songdo Plant 1

LOTTE Biologics signs its commercial manufacturing agreement for Songdo Plant 1 with a global pharmaceutical company, with production expected to begin in 2027.

Songdo Plant 1 In South Korea | 18/11/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members